These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1545082)

  • 1. Further evidence in support of anticoagulant therapy before elective cardioversion of atrial fibrillation.
    DiMarco JP
    J Am Coll Cardiol; 1992 Mar; 19(4):856-7. PubMed ID: 1545082
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of prophylactic anticoagulation for direct current cardioversion in patients with atrial fibrillation or atrial flutter.
    Arnold AZ; Mick MJ; Mazurek RP; Loop FD; Trohman RG
    J Am Coll Cardiol; 1992 Mar; 19(4):851-5. PubMed ID: 1545081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physician practices regarding anticoagulation and cardioversion of atrial fibrillation.
    Schlicht JR; Davis RC; Naqi K; Cooper W; Rao BV
    Arch Intern Med; 1996 Feb; 156(3):290-4. PubMed ID: 8572839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prophylactic administration of anticoagulant therapy in electric cardioversion for atrial fibrillation or atrial flutter].
    Jirmár R; Gregor P
    Cor Vasa; 1993; 35(3):K81-2. PubMed ID: 8348810
    [No Abstract]   [Full Text] [Related]  

  • 5. Benefits and risks of thrombolytic, anticoagulant and antiplatelet therapies in atrial fibrillation.
    Marchant BG; Timmis AD
    Br J Hosp Med; 1993 Feb 3-16; 49(3):186-90. PubMed ID: 8439785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticoagulation for cardioversion of atrial fibrillation.
    Weinberg DM; Mancini J
    Am J Cardiol; 1989 Mar; 63(11):745-6. PubMed ID: 2923062
    [No Abstract]   [Full Text] [Related]  

  • 7. The efficacy of anticoagulant therapy in preventing embolism related to D.C. electrical conversion of atrial fibrillation.
    Bjerkelund CJ; Orning OM
    Am J Cardiol; 1969 Feb; 23(2):208-16. PubMed ID: 4180019
    [No Abstract]   [Full Text] [Related]  

  • 8. A review of direct current cardioversions for atrial arrhythmia.
    Johnston SD; Trouton TG; Wilson C
    Ulster Med J; 1998 May; 67(1):19-24. PubMed ID: 9652194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardioversion of atrial fibrillation: consideration of embolization, anticoagulation, prophylactic pacemaker, and long-term success.
    Mancini GB; Goldberger AL
    Am Heart J; 1982 Sep; 104(3):617-21. PubMed ID: 7113903
    [No Abstract]   [Full Text] [Related]  

  • 10. Anticoagulation in nonvalvular atrial fibrillation.
    Borresen T
    J La State Med Soc; 1996 Nov; 148(11):479-84. PubMed ID: 8990787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardioversion of atrial fibrillation.
    Lip GY
    Postgrad Med J; 1995 Aug; 71(838):457-65. PubMed ID: 7567751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of embolism in elective cardioversion of atrial fibrillation.
    Mancini GB
    G Ital Cardiol; 1994 Mar; 24(3):331-40. PubMed ID: 8063069
    [No Abstract]   [Full Text] [Related]  

  • 13. Incidence of spontaneous echocontrast, 'sludge' and thrombi before cardioversion in patients with atrial fibrillation: new insights into the role of transesophageal echocardiography.
    Maltagliati A; Galli CA; Tamborini G; Celeste F; Muratori M; Pepi M
    J Cardiovasc Med (Hagerstown); 2009 Jul; 10(7):523-8. PubMed ID: 19474574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [On the prophylactic use of synthetic anticoagulants before cardioversion in atrial fibrillation].
    Fiori W; Civai O
    Atti Accad Fisiocrit Siena Med Fis; 1966; 15(1):67-76. PubMed ID: 6001460
    [No Abstract]   [Full Text] [Related]  

  • 15. [Stroke and other thromboembolic complications of atrial fibrillation. Part VII. Prevention of cardioversion related thromboembolism].
    Preobrazhenskiĭ DV; Sidorenko BA; Kiktev VG; Batyraliev TA; Pershukov IV
    Kardiologiia; 2005; 45(7):78-82. PubMed ID: 16091669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atrial fibrillation and anticoagulation.
    Marcus RR; Atwood JE
    Adv Intern Med; 1999; 44():239-65. PubMed ID: 9929711
    [No Abstract]   [Full Text] [Related]  

  • 17. [Auricular fibrillation, systemic embolism and anticoagulant treatment].
    Thumala A; Kauffmann R
    Rev Med Chil; 1993 Jun; 121(6):686-92. PubMed ID: 8278707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Should all patients undergo transesophageal echocardiography before electrical cardioversion of atrial fibrillation?
    Grimm RA; Stewart WJ; Black IW; Thomas JD; Klein AL
    J Am Coll Cardiol; 1994 Feb; 23(2):533-41. PubMed ID: 8294710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rationale and design of the eXplore the efficacy and safety of once-daily oral riVaroxaban for the prEvention of caRdiovascular events in patients with nonvalvular aTrial fibrillation scheduled for cardioversion trial: A comparison of oral rivaroxaban once daily with dose-adjusted vitamin K antagonists in patients with nonvalvular atrial fibrillation undergoing elective cardioversion.
    Ezekowitz MD; Cappato R; Klein AL; Camm AJ; Ma CS; Le Heuzey JY; Talajic M; Scanavacca MI; Vardas PE; Kirchhof P; Hohnloser SH; Hemmrich M; Lanius V; Meng IL; Wildgoose P; van Eickels M
    Am Heart J; 2014 May; 167(5):646-52. PubMed ID: 24766973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experience in daily clinical practice of ambulatory cardioversion of atrial fibrillation treated with new oral anticoagulants.
    Santas E; Méndez J; Martínez-Brotons A; Núñez J; Chorro FJ; Ruiz-Granell R
    Rev Esp Cardiol (Engl Ed); 2014 Nov; 67(11):960-1. PubMed ID: 25242661
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.